Topical antiviral formulations

a technology of antiviral and topical formulations, which is applied in the field of formulations with antiviral activity, can solve the problems of not always using safe-sex techniques, not always using them properly, and not always using current safe-sex techniques, so as to increase the probability of composition us

Inactive Publication Date: 2006-03-16
EASTERN VIRGINIA MEDICAL SCHOOL +1
View PDF23 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0009] If desired, flavorants, scents, fragrances, and colorants may be incorporated into the composition so long as they do not interfere with the safety or efficacy of the composition. Inde...

Problems solved by technology

Human immunodeficiency virus (HIV) infection and related diseases are a major public health problem worldwide.
Even with their known effectiveness in preventing STDs, current safe-sex techniques are not always used, or are not always used properly, for many reasons (e.g. carelessnes...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Topical antiviral formulations
  • Topical antiviral formulations
  • Topical antiviral formulations

Examples

Experimental program
Comparison scheme
Effect test

examples

[0056] The following examples further describe and demonstrate particular embodiments within the scope of the present invention. The examples are given solely for illustration and are not to be construed as limitations as many variations are possible without departing from spirit and scope of the Invention. The following examples are intended for illustration only and are not intended to limit the scope of the invention in any way. “Active ingredient” denotes one or more NRTIs, as defined above, preferably tenofovir or a physiologically functional derivative thereof.

Formulation A (Controlled Release Formulation):

[0057] This formulation is prepared by wet granulation of the ingredients with purified water, followed by the addition of magnesium stearate and compression. The hypromellose can utilize varying viscosity grades.

mg / tabletActive ingredient300Hypromellose112Lactose Monohydrate53Pregelatinized Starch28Magnesium Stearate7Purified Waterq.s.

Drug release takes place over a p...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Percent by massaaaaaaaaaa
Massaaaaaaaaaa
Massaaaaaaaaaa
Login to view more

Abstract

The present invention relates to formulations of nucleotide reverse transcriptase inhibitors (NRTIs), preferably [2-(6-Amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid (tenofovir, PMPA), or a physiologically functional derivative thereof, suitable for topical application and their use in the prevention of HIV infections.

Description

FIELD OF THE INVENTION [0001] The invention relates generally to formulations of compounds with antiviral activity and more specifically with anti-HIV properties. BACKGROUND OF THE INVENTION [0002] Human immunodeficiency virus (HIV) infection and related diseases are a major public health problem worldwide. One approach to the problem of HIV / AIDS is to reduce the risk of transmission of HIV and thus reduce the number of individuals who become newly infected. Even when treatments or cures become available, prevention of infections in the initial instance will likely remain as the first line of defense. For medical, psychological, and economic reasons, it is preferable to prevent the initial infection, rather than treating, individuals with AIDS. [0003] Education in regard to sexually transmitted diseases (STDs), their modes of transmission, and so-called “safe-sex” techniques has shown some promise in reducing the risks of STD transmission through sexual activity. Screening of the bl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/675
CPCA61K9/0014A61K9/02A61F6/04A61K31/675A61K31/505A61P15/00A61P31/00A61P31/12A61P31/18A61P43/00A61K9/16A61K9/48A61K9/12A61K9/0034
Inventor DAHL, TERRENCE C.
Owner EASTERN VIRGINIA MEDICAL SCHOOL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap